Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Warner Bros. Discovery Series A Stock (NASDAQ: WBD) on Dec. 16, 2025: Takeover Battle, Latest News, Analyst Forecasts, and What Comes Next

Warner Bros. Discovery Series A Stock (NASDAQ: WBD) on Dec. 16, 2025: Takeover Battle, Latest News, Analyst Forecasts, and What Comes Next

NEW YORK — Warner Bros. Discovery, Inc. Series A shares (NASDAQ: WBD) are trading like a merger-arbitrage ticker rather than a traditional media stock on Tuesday, Dec. 16, 2025, with the price effectively “pinned” near $30 as investors handicap two competing endgames: Paramount Skydance’s $30-per-share all-cash tender offer versus Netflix’s prior agreement to acquire key WBD assets at a $27.75…
Texas Instruments (TXN) Stock News Today: Goldman Sachs Downgrade, Sherman Fab Ramp, and Wall Street Forecasts (Dec. 16, 2025)

Texas Instruments (TXN) Stock News Today: Goldman Sachs Downgrade, Sherman Fab Ramp, and Wall Street Forecasts (Dec. 16, 2025)

Texas Instruments Incorporated (NASDAQ: TXN) is back in the spotlight on December 16, 2025, as investors balance two forces moving in opposite directions: near-term pressure on the earnings story (highlighted by a high-profile Wall Street downgrade) and long-term confidence in the company’s U.S. manufacturing buildout, including a major Sherman, Texas production milestone expected this week. With TXN trading modestly lower…
Lululemon Stock (LULU) News Today: CEO Transition, Nasdaq-100 Exit, Buyback Boost and Fresh Analyst Forecasts (Dec. 16, 2025)

Lululemon Stock (LULU) News Today: CEO Transition, Nasdaq-100 Exit, Buyback Boost and Fresh Analyst Forecasts (Dec. 16, 2025)

Dec. 16, 2025 — lululemon athletica inc. (NASDAQ: LULU) is back in the spotlight this week after a rapid-fire sequence of headlines reshaped the near-term narrative around the athleisure leader: a CEO succession plan, an earnings beat with updated guidance, an expanded share repurchase authorization, and confirmation that the company will be removed from the Nasdaq-100 during the index’s annual…
Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus on Tuesday, December 16, 2025, after a strong rebound in the prior session and a fresh wave of market commentary ranging from technical-analysis signals to institutional-filings headlines and updated Wall Street expectations. As of late morning U.S. trading, ISRG traded around $548–$549, down roughly 2% on the day, valuing the surgical-robotics…
Applied Materials (AMAT) Stock News Today (Dec. 16, 2025): Analyst Price Targets Jump as SEMI Forecasts a Record $156B Equipment Market by 2027

Applied Materials (AMAT) Stock News Today (Dec. 16, 2025): Analyst Price Targets Jump as SEMI Forecasts a Record $156B Equipment Market by 2027

Applied Materials, Inc. (NASDAQ: AMAT) is back in the spotlight on December 16, 2025, as fresh industry forecasts and a wave of Wall Street price-target increases reinforce a central narrative for semiconductor equipment investors: the AI buildout is pulling forward demand for leading-edge logic, memory (especially HBM-related DRAM), and advanced packaging—exactly the mix where Applied Materials has been positioning its…
Merck (MRK) Stock News Today: Why Shares Slid on Dec. 16, 2025 as Analysts Reassess Keytruda, Winrevair, and Merck’s Post‑Patent Strategy

Merck (MRK) Stock News Today: Why Shares Slid on Dec. 16, 2025 as Analysts Reassess Keytruda, Winrevair, and Merck’s Post‑Patent Strategy

Merck & Co., Inc. (NYSE: MRK) stock was among the biggest drags on the Dow Jones Industrial Average in Tuesday’s session (December 16, 2025), with shares trading lower as investors weighed broad market pressure alongside a fast-moving set of company-specific catalysts—ranging from regulatory momentum for Winrevair to ongoing efforts to protect Keytruda ahead of looming patent headwinds. MarketWatch As of…
IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Falling, What Analysts Forecast, and How the Microsoft AI Deal Shapes 2026 (Dec. 16, 2025)

IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Falling, What Analysts Forecast, and How the Microsoft AI Deal Shapes 2026 (Dec. 16, 2025)

IREN Limited stock is back in the spotlight on December 16, 2025, as the high-flying “AI infrastructure” trade collides with a sharp momentum pullback — even while the company continues to point to a massive long-term runway from its GPU cloud pivot and headline-grabbing Microsoft agreement. As of 16:39 UTC on Dec. 16, IREN was trading around $34.19, down about…
Carvana Stock (CVNA) News Today, Dec. 16, 2025: Argus Starts Coverage With a $500 Target as S&P 500 Entry Nears

Carvana Stock (CVNA) News Today, Dec. 16, 2025: Argus Starts Coverage With a $500 Target as S&P 500 Entry Nears

Carvana Co. (NYSE: CVNA) is back at the center of Wall Street’s attention on December 16, 2025, as the online used‑car retailer heads toward a major index milestone and picks up fresh analyst support. Shares were trading at $457.76, up about 2.2% on the session, after moving between $445.00 and $464.29 intraday (about 1.39 million shares traded as of 16:31…
Goldman Sachs (GS) Stock News Today: Fed Ends 1MDB-Linked Order as Goldman Targets AI Deals and the 24/7 Trading Era

Goldman Sachs (GS) Stock News Today: Fed Ends 1MDB-Linked Order as Goldman Targets AI Deals and the 24/7 Trading Era

Goldman Sachs Group, Inc. (The) stock (NYSE: GS) is back in the spotlight on December 16, 2025, with a mix of regulatory, strategic, and market-structure headlines landing as the shares hover near recent highs. As of the latest available market data on Dec. 16, GS traded around $881.68, down about 0.9% versus the prior close. That price action comes as…
Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

December 16, 2025 — Johnson & Johnson stock (NYSE: JNJ) is trading lower on Tuesday after pushing to fresh highs earlier this week, as investors weigh a mix of pipeline momentum, legal headlines, and an approaching earnings update that could clarify the company’s 2026 trajectory. StockAnalysis Below is what’s moving Johnson & Johnson shares right now, what Wall Street is…
Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America Corporation (NYSE: BAC) is trading near a multi‑year peak on Tuesday, December 16, 2025, with investors weighing (1) a fresh round of U.S. labor-market data that’s reshaping expectations for the Federal Reserve’s next move, (2) new regulatory and consumer-banking fee headlines, and (3) the countdown to Bank of America’s fourth‑quarter 2025 earnings report on January 14, 2026.…
Rocket Lab Stock (RKLB) News Today: JAXA Mission Win, Launch Abort, Insider Sale Filing, and 2026 Forecasts (Dec. 16, 2025)

Rocket Lab Stock (RKLB) News Today: JAXA Mission Win, Launch Abort, Insider Sale Filing, and 2026 Forecasts (Dec. 16, 2025)

Rocket Lab Corporation (NASDAQ: RKLB) is back in the spotlight on Tuesday, December 16, 2025, after a volatile two-day stretch that captured both the promise—and the whiplash—of the fast-growing space economy. In late-morning trading, Rocket Lab stock hovered in the mid-$50s after a sharp pullback earlier in the week. Investing.com showed RKLB at $54.575, down 1.51% on the day at…
1 637 638 639 640 641 856

Stock Market Today

  • Prologis Price Target Shift Alters Market Narrative, Analysts Weigh In
    January 28, 2026, 5:31 AM EST. Prologis (PLD) has experienced a notable shift in its price target, signaling changes in analyst expectations and investor sentiment. The revised target reflects updated assumptions about rental income, development activity, and funding costs amid fluctuating interest rates. This adjustment offers a new benchmark for Prologis's fair value but does not guarantee future returns, highlighting uncertainty in market pricing. Investors are encouraged to reassess their investment theses and portfolio roles in light of these changes. The narrative surrounding Prologis is evolving, with input from a broad community of over 7 million investors providing diverse perspectives on the stock's outlook. Tracking these shifts via updated price targets and analyst views remains crucial for informed decision-making.
Go toTop